Impact BioMedical, Financials
| IBO Stock | USD 0.67 0.00 0.000003% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.23 | 0.4 |
|
| |||||
| Current Ratio | 1.74 | 1.84 |
|
|
The financial analysis of Impact BioMedical, is a critical element in measuring its lifeblood. Investors should not minimize Impact BioMedical,'s ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Impact | Select Account or Indicator |
Understanding current and past Impact BioMedical, Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Impact BioMedical,'s financial statements are interrelated, with each one affecting the others. For example, an increase in Impact BioMedical,'s assets may result in an increase in income on the income statement.
Impact BioMedical, Stock Summary
Impact BioMedical, competes with Merrill Lynch, Eagle Capital, and Ellomay Capital. Impact BioMedical, is entity of United States. It is traded as Stock on NYSE MKT exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NYSE MKT Exchange |
| CUSIP | 45259L205 |
| Location | Texas; U.S.A |
| Business Address | 1400 Broadfield Blvd, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.impactbiomedinc.com |
| Phone | 585 325 3610 |
| Currency | USD - US Dollar |
Impact BioMedical, Key Financial Ratios
| Return On Equity | 0.0345 | ||||
| Net Income | (4.34 M) | ||||
| Book Value Per Share | 2.72 X | ||||
| Market Capitalization | 7.64 M | ||||
| Total Asset | 44.63 M |
Impact Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Impact BioMedical,'s current stock value. Our valuation model uses many indicators to compare Impact BioMedical, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Impact BioMedical, competition to find correlations between indicators driving Impact BioMedical,'s intrinsic value. More Info.Impact BioMedical, is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . At this time, Impact BioMedical,'s Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Impact BioMedical,'s earnings, one of the primary drivers of an investment's value.Impact BioMedical, Systematic Risk
Impact BioMedical,'s systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Impact BioMedical, volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Impact BioMedical, correlated with the market. If Beta is less than 0 Impact BioMedical, generally moves in the opposite direction as compared to the market. If Impact BioMedical, Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Impact BioMedical, is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Impact BioMedical, is generally in the same direction as the market. If Beta > 1 Impact BioMedical, moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Impact BioMedical, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Impact BioMedical,'s growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Impact BioMedical, growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Impact BioMedical, March 14, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Impact BioMedical, help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Impact BioMedical,. We use our internally-developed statistical techniques to arrive at the intrinsic value of Impact BioMedical, based on widely used predictive technical indicators. In general, we focus on analyzing Impact Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Impact BioMedical,'s daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 57.71 | |||
| Value At Risk | (22.35) | |||
| Potential Upside | 20.63 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.